HOWL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,594,955.85

Werewolf Therapeutics Insider Trading History Chart

Werewolf Therapeutics Share Price & Price History

^$0.96

▲ +0.0165 (1.75%)

As of 09/1/2026 04:00 PM ET

Days: 30 | 90 | 365

Werewolf Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/7/2026	Luke Evnin	Director	Sell	107,429	$0.31	$33,302.99
7/6/2026	Luke Evnin	Director	Sell	35,770	$0.32	$11,446.40	107,429
6/17/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	416,911	$0.35	$145,918.85	303,719
6/16/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	149,625	$0.37	$55,361.25	331,414
6/15/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	128,770	$0.39	$50,220.30	341,353
6/12/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	170,441	$0.40	$68,176.40	349,907
6/11/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	262,503	$0.38	$99,751.14	361,229
6/10/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	45,923	$0.37	$16,991.51	378,666
6/9/2026	Luke Evnin	Director	Sell	76,928	$0.37	$28,463.36	300,283
6/9/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	369,800	$0.37	$136,826.00	381,717
6/8/2026	Luke Evnin	Director	Sell	60,547	$0.40	$24,218.80	377,211
6/5/2026	Luke Evnin	Director	Sell	24,946	$0.40	$9,978.40	437,758
6/4/2026	Luke Evnin	Director	Sell	20,072	$0.44	$8,831.68	462,704
6/3/2026	Luke Evnin	Director	Sell	29,749	$0.42	$12,494.58	482,776
6/2/2026	Luke Evnin	Director	Sell	29,595	$0.45	$13,317.75	512,525
6/1/2026	Luke Evnin	Director	Sell	80,459	$0.47	$37,815.73	542,120
5/29/2026	Luke Evnin	Director	Sell	32,556	$0.45	$14,650.20	622,579
5/28/2026	Luke Evnin	Director	Sell	27,698	$0.46	$12,741.08	655,135
5/27/2026	Luke Evnin	Director	Sell	80,852	$0.48	$38,808.96	682,833
5/26/2026	Luke Evnin	Director	Sell	67,950	$0.47	$31,936.50	763,685
5/22/2026	Luke Evnin	Director	Sell	87,425	$0.45	$39,341.25	831,635
5/21/2026	Luke Evnin	Director	Sell	36,387	$0.42	$15,282.54	919,060
5/20/2026	Luke Evnin	Director	Sell	85,895	$0.43	$36,934.85	955,447
5/19/2026	Luke Evnin	Director	Sell	62,970	$0.45	$28,336.50	1,041,342
5/18/2026	Luke Evnin	Director	Sell	22,184	$0.50	$11,092.00	1,104,312
5/12/2026	Luke Evnin	Director	Sell	67,885	$0.64	$43,446.40	1,171,175
5/12/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	101,151	$0.64	$64,736.64	406,282
5/11/2026	Luke Evnin	Director	Sell	33,948	$0.67	$22,745.16	1,239,060
5/11/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	87,490	$0.67	$58,618.30	413,001
5/8/2026	Luke Evnin	Director	Sell	305,741	$0.70	$214,018.70	1,273,008
5/8/2026	Ra Capital Management, L.P.	Major Shareholder	Sell	376,526	$0.71	$267,333.46	418,813
5/7/2026	Luke Evnin	Director	Sell	79,086	$0.63	$49,824.18	1,578,749
5/6/2026	Luke Evnin	Director	Sell	14,635	$0.66	$9,659.10	1,657,835
5/5/2026	Luke Evnin	Director	Sell	6,860	$0.69	$4,733.40	1,672,470
5/4/2026	Luke Evnin	Director	Sell	47,963	$0.72	$34,533.36	1,679,330
5/1/2026	Luke Evnin	Director	Sell	58,394	$0.73	$42,627.62	1,727,293
4/30/2026	Luke Evnin	Director	Sell	168,262	$0.72	$121,148.64	1,785,687
4/29/2026	Luke Evnin	Director	Sell	56,559	$0.69	$39,025.71	1,953,949
4/28/2026	Luke Evnin	Director	Sell	95,412	$0.73	$69,650.76	2,010,508
4/27/2026	Luke Evnin	Director	Sell	53,940	$0.85	$45,849.00	2,105,920
1/16/2026	Luke Evnin	Director	Sell	38,782	$0.54	$20,942.28	2,159,860
1/15/2026	Luke Evnin	Director	Sell	37,413	$0.55	$20,577.15	2,198,642
1/14/2026	Luke Evnin	Director	Sell	30,616	$0.57	$17,451.12	2,236,055
1/13/2026	Luke Evnin	Director	Sell	43,198	$0.55	$23,758.90	2,266,671
1/12/2026	Luke Evnin	Director	Sell	58,980	$0.57	$33,618.60	2,309,869
1/9/2026	Luke Evnin	Director	Sell	24,678	$0.61	$15,053.58	2,368,849
1/8/2026	Luke Evnin	Director	Sell	7,716	$0.63	$4,861.08	2,393,527
1/7/2026	Luke Evnin	Director	Sell	11,915	$0.64	$7,625.60	2,401,243
1/6/2026	Luke Evnin	Director	Sell	40,761	$0.65	$26,494.65	2,413,158
1/5/2026	Luke Evnin	Director	Sell	18,378	$0.64	$11,761.92	2,453,919
1/2/2026	Luke Evnin	Director	Sell	18,568	$0.63	$11,697.84	2,472,297
12/31/2025	Luke Evnin	Director	Sell	24,962	$0.62	$15,476.44	2,490,865
12/30/2025	Luke Evnin	Director	Sell	34,847	$0.61	$21,256.67	2,515,827
12/29/2025	Luke Evnin	Director	Sell	108,606	$0.61	$66,249.66	2,550,674
12/26/2025	Luke Evnin	Director	Sell	35,632	$0.63	$22,448.16	2,659,280
12/24/2025	Luke Evnin	Director	Sell	16,310	$0.65	$10,601.50	2,694,912
12/23/2025	Luke Evnin	Director	Sell	71,428	$0.63	$44,999.64	2,711,222
12/22/2025	Luke Evnin	Director	Sell	59,307	$0.69	$40,921.83	2,782,650
12/17/2025	Luke Evnin	Director	Sell	9,983	$1.14	$11,380.62	2,841,957
12/16/2025	Luke Evnin	Director	Sell	14,548	$1.05	$15,275.40	2,851,940
12/15/2025	Luke Evnin	Director	Sell	23,640	$1.07	$25,294.80	2,866,488
12/12/2025	Luke Evnin	Director	Sell	17,858	$1.08	$19,286.64	2,890,128
12/11/2025	Luke Evnin	Director	Sell	28,009	$1.07	$29,969.63	2,907,986
12/10/2025	Luke Evnin	Director	Sell	37,104	$1.06	$39,330.24	2,935,995
12/9/2025	Luke Evnin	Director	Sell	44,570	$1.01	$45,015.70	2,973,099
12/8/2025	Luke Evnin	Director	Sell	34,041	$0.99	$33,700.59	3,017,669
12/5/2025	Luke Evnin	Director	Sell	16,568	$0.97	$16,070.96	3,051,710
12/4/2025	Ansbert Gadicke	Major Shareholder	Sell	83,230	$0.97	$80,733.10	4,784,111
12/4/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	83,230	$0.97	$80,733.10	4,784,111
12/4/2025	Luke Evnin	Director	Sell	53,416	$0.97	$51,813.52	3,068,278
12/3/2025	Ansbert Gadicke	Major Shareholder	Sell	57,225	$0.87	$49,785.75	4,867,341
12/3/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	57,225	$0.87	$49,785.75	4,867,341
12/3/2025	Luke Evnin	Director	Sell	36,726	$0.87	$31,951.62	3,121,694
12/2/2025	Ansbert Gadicke	Major Shareholder	Sell	59,277	$0.89	$52,756.53	4,924,566
12/2/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	59,277	$0.89	$52,756.53	4,924,566
12/2/2025	Luke Evnin	Director	Sell	38,043	$0.89	$33,858.27	3,158,420
12/1/2025	Ansbert Gadicke	Major Shareholder	Sell	60,917	$0.94	$57,261.98	4,983,843
12/1/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	60,917	$0.94	$57,261.98	4,983,843
12/1/2025	Luke Evnin	Director	Sell	39,096	$0.94	$36,750.24	3,196,463
11/28/2025	Ansbert Gadicke	Major Shareholder	Sell	20,277	$0.99	$20,074.23	5,044,760
11/28/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	20,277	$0.99	$20,074.23	5,044,760
11/28/2025	Luke Evnin	Director	Sell	13,014	$0.99	$12,883.86	3,235,559
11/26/2025	Ansbert Gadicke	Major Shareholder	Sell	60,733	$0.98	$59,518.34	5,065,037
11/26/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	60,733	$0.98	$59,518.34	5,065,037
11/26/2025	Luke Evnin	Director	Sell	38,978	$0.98	$38,198.44	3,248,573
11/25/2025	Ansbert Gadicke	Major Shareholder	Sell	42,533	$0.92	$39,130.36	5,125,770
11/25/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	42,533	$0.92	$39,130.36	5,125,770
11/25/2025	Luke Evnin	Director	Sell	27,297	$0.92	$25,113.24	3,287,551
11/24/2025	Ansbert Gadicke	Major Shareholder	Sell	88,802	$0.98	$87,025.96	5,168,303
11/24/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	88,802	$0.98	$87,025.96	5,168,303
11/24/2025	Luke Evnin	Director	Sell	56,992	$0.98	$55,852.16	3,314,848
11/21/2025	Ansbert Gadicke	Major Shareholder	Sell	64,331	$0.83	$53,394.73	5,257,105
11/21/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	64,331	$0.83	$53,394.73	5,257,105
11/21/2025	Luke Evnin	Director	Sell	41,287	$0.83	$34,268.21	3,371,840
11/20/2025	Ansbert Gadicke	Major Shareholder	Sell	41,152	$0.89	$36,625.28	5,321,436
11/20/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	41,152	$0.89	$36,625.28	5,321,436
11/20/2025	Luke Evnin	Director	Sell	26,411	$0.89	$23,505.79	3,413,127
11/19/2025	Ansbert Gadicke	Major Shareholder	Sell	66,324	$0.94	$62,344.56	5,362,588
11/19/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	66,324	$0.94	$62,344.56	5,362,588
11/19/2025	Luke Evnin	Director	Sell	42,566	$0.94	$40,012.04	3,439,538
11/18/2025	Ansbert Gadicke	Major Shareholder	Sell	52,627	$0.93	$48,943.11	5,428,912
11/18/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	52,627	$0.93	$48,943.11	5,428,912
11/18/2025	Luke Evnin	Director	Sell	33,776	$0.93	$31,411.68	3,482,104
11/17/2025	Ansbert Gadicke	Major Shareholder	Sell	57,061	$0.95	$54,207.95	5,481,539
11/17/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	57,061	$0.95	$54,207.95	5,481,539
11/17/2025	Luke Evnin	Director	Sell	36,621	$0.95	$34,789.95	3,515,880
11/14/2025	Ansbert Gadicke	Major Shareholder	Sell	61,640	$0.93	$57,325.20	5,538,600
11/14/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	61,640	$0.93	$57,325.20	5,538,600
11/14/2025	Luke Evnin	Director	Sell	39,560	$0.93	$36,790.80	3,552,501
11/13/2025	Ansbert Gadicke	Major Shareholder	Sell	90,951	$0.98	$89,131.98	5,600,240
11/13/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	90,951	$0.98	$89,131.98	5,600,240
11/13/2025	Luke Evnin	Director	Sell	58,372	$0.98	$57,204.56	3,592,061
11/12/2025	Ansbert Gadicke	Major Shareholder	Sell	40,669	$1.09	$44,329.21	5,691,191
11/12/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	40,669	$1.09	$44,329.21	5,691,191
11/12/2025	Luke Evnin	Director	Sell	26,101	$1.09	$28,450.09	3,650,433
11/11/2025	Ansbert Gadicke	Major Shareholder	Sell	55,810	$1.14	$63,623.40	5,731,860
11/11/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	55,810	$1.14	$63,623.40	5,731,860
11/11/2025	Luke Evnin	Director	Sell	35,818	$1.14	$40,832.52	3,676,534
11/10/2025	Ansbert Gadicke	Major Shareholder	Sell	48,570	$1.18	$57,312.60	5,787,670
11/10/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	48,570	$1.18	$57,312.60	5,787,670
11/10/2025	Luke Evnin	Director	Sell	31,172	$1.18	$36,782.96	3,712,352
11/7/2025	Ansbert Gadicke	Major Shareholder	Sell	68,480	$1.11	$76,012.80	5,836,240
11/7/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	68,480	$1.11	$76,012.80	5,836,240
11/7/2025	Luke Evnin	Director	Sell	43,950	$1.11	$48,784.50	3,743,524
11/6/2025	Ansbert Gadicke	Major Shareholder	Sell	54,452	$1.21	$65,886.92	5,904,720
11/6/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	54,452	$1.21	$65,886.92	5,904,720
11/6/2025	Luke Evnin	Director	Sell	34,947	$1.21	$42,285.87	3,787,474
11/5/2025	Ansbert Gadicke	Major Shareholder	Sell	47,950	$1.22	$58,499.00	5,959,172
11/5/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	47,950	$1.22	$58,499.00	5,959,172
11/5/2025	Luke Evnin	Director	Sell	30,774	$1.22	$37,544.28	3,822,421
11/4/2025	Ansbert Gadicke	Major Shareholder	Sell	140,488	$1.22	$171,395.36	6,007,122
11/4/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	140,488	$1.22	$171,395.36	6,007,122
11/4/2025	Luke Evnin	Director	Sell	90,164	$1.22	$110,000.08	3,853,195
11/3/2025	Ansbert Gadicke	Major Shareholder	Sell	94,063	$1.29	$121,341.27	6,147,610
11/3/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	94,063	$1.29	$121,341.27	6,147,610
11/3/2025	Luke Evnin	Director	Sell	60,369	$1.29	$77,876.01	3,943,359
10/31/2025	Ansbert Gadicke	Major Shareholder	Sell	114,044	$1.28	$145,976.32	6,241,673
10/31/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	114,044	$1.28	$145,976.32	6,241,673
10/31/2025	Luke Evnin	Director	Sell	73,192	$1.28	$93,685.76	4,003,728
10/30/2025	Ansbert Gadicke	Major Shareholder	Sell	86,936	$1.43	$124,318.48	6,355,717
10/30/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	86,936	$1.43	$124,318.48	6,355,717
10/30/2025	Luke Evnin	Director	Sell	55,795	$1.43	$79,786.85	4,076,920
10/29/2025	Ansbert Gadicke	Major Shareholder	Sell	134,240	$1.55	$208,072.00	6,442,653
10/29/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	134,240	$1.55	$208,072.00	6,442,653
10/29/2025	Luke Evnin	Director	Sell	86,154	$1.55	$133,538.70	4,132,715
10/28/2025	Ansbert Gadicke	Major Shareholder	Sell	69,068	$1.64	$113,271.52	6,576,893
10/28/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	69,068	$1.64	$113,271.52	6,576,893
10/28/2025	Luke Evnin	Director	Sell	44,327	$1.64	$72,696.28	4,218,869
10/27/2025	Ansbert Gadicke	Major Shareholder	Sell	72,709	$1.72	$125,059.48	6,645,961
10/27/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	72,709	$1.72	$125,059.48	6,645,961
10/27/2025	Luke Evnin	Director	Sell	46,664	$1.72	$80,262.08	4,263,196
5/14/2025	Ra Capital Management, L.P.	Director	Buy	162,539	$0.98	$159,288.22	6,237,482
5/12/2025	Ra Capital Management, L.P.	Director	Buy	320,913	$0.86	$275,985.18	6,021,969
3/27/2025	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	1,963	$1.05	$2,061.15	3,208,793
3/27/2025	Luke Evnin	Director	Sell	2,425	$1.05	$2,546.25	4,309,860

SEC Filings (Institutional Ownership Changes) for Werewolf Therapeutics (NASDAQ:HOWL)

64.84% of Werewolf Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Werewolf Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/17/2026	Bank of America Corp DE	311,502	$0.11M	0.0%	N/A	0.641%
8/7/2026	BlackRock Inc.	101,573	$37K	0.0%	N/A	0.209%
5/19/2026	Bank of America Corp DE	264,583	$0.22M	0.0%	-64.1%	0.544%
5/14/2026	Renaissance Technologies LLC	516,218	$0.43M	0.0%	-23.8%	1.062%
2/18/2026	Millennium Management LLC	240,109	$0.15M	0.0%	-24.3%	0.495%
2/18/2026	Bridgeway Capital Management LLC	77,000	$49K	0.0%	-24.5%	0.159%
2/17/2026	MPM Bioimpact LLC	1,393,557	$0.88M	0.1%	-42.1%	2.871%
2/17/2026	Regal Investment Advisors LLC	52,593	$33K	0.0%	+93.3%	0.108%
2/13/2026	Vontobel Holding Ltd.	60,003	$38K	0.0%	+66.7%	0.124%
2/12/2026	Jane Street Group LLC	157,322	$100K	0.0%	-41.4%	0.324%
2/12/2026	Renaissance Technologies LLC	677,766	$0.43M	0.0%	+48.6%	1.396%
11/17/2025	Susquehanna International Group LLP	93,041	$0.18M	0.0%	+16.9%	0.192%
11/17/2025	Qube Research & Technologies Ltd	29,250	$58K	0.0%	-33.9%	0.060%
11/17/2025	Millennium Management LLC	317,053	$0.63M	0.0%	-54.5%	0.653%
11/17/2025	Citadel Advisors LLC	154,534	$0.30M	0.0%	N/A	0.318%
11/17/2025	Bank of America Corp DE	1,830,292	$3.61M	0.0%	-14.0%	3.771%
11/14/2025	Two Sigma Investments LP	20,139	$40K	0.0%	-55.7%	0.041%
11/7/2025	Vanguard Group Inc.	1,408,047	$2.77M	0.0%	+8.5%	2.901%
8/15/2025	Bridgeway Capital Management LLC	102,000	$0.11M	0.0%	+157.7%	0.227%
8/15/2025	Bank of America Corp DE	2,129,024	$2.32M	0.0%	+1.2%	4.745%
8/14/2025	Jane Street Group LLC	374,939	$0.41M	0.0%	N/A	0.836%
8/14/2025	Qube Research & Technologies Ltd	44,261	$48K	0.0%	N/A	0.099%
8/13/2025	Marshall Wace LLP	103,785	$0.11M	0.0%	N/A	0.231%
8/13/2025	Quadrature Capital Ltd	25,791	$28K	0.0%	N/A	0.057%
8/8/2025	Geode Capital Management LLC	327,955	$0.36M	0.0%	-54.3%	0.731%
8/1/2025	Y Intercept Hong Kong Ltd	84,421	$92K	0.0%	N/A	0.188%
6/27/2025	Goldman Sachs Group Inc.	111,985	$0.11M	0.0%	-21.0%	0.250%
5/16/2025	Goldman Sachs Group Inc.	111,985	$0.11M	0.0%	-21.0%	0.250%
5/16/2025	AQR Capital Management LLC	81,669	$79K	0.0%	N/A	0.182%
5/15/2025	MPM Bioimpact LLC	2,408,810	$2.34M	0.4%	+0.9%	5.368%
5/15/2025	MPM Asset Management LLC	4,309,860	$4.19M	6.0%	+0.6%	9.604%
5/14/2025	Walleye Capital LLC	59,347	$58K	0.0%	-38.7%	0.132%
5/12/2025	Nuveen LLC	73,370	$71K	0.0%	N/A	0.164%
5/9/2025	Charles Schwab Investment Management Inc.	95,712	$93K	0.0%	+33.2%	0.213%
4/28/2025	Vontobel Holding Ltd.	35,000	$34K	0.0%	N/A	0.078%
2/17/2025	Two Sigma Investments LP	93,440	$0.14M	0.0%	-48.3%	0.210%
2/17/2025	Two Sigma Advisers LP	139,100	$0.21M	0.0%	-45.7%	0.312%
2/17/2025	Millennium Management LLC	596,289	$0.88M	0.0%	-55.0%	1.338%
2/17/2025	Deutsche Bank AG	101,626	$0.15M	0.0%	+450.7%	0.228%
2/17/2025	D. E. Shaw & Co. Inc.	17,776	$26K	0.0%	N/A	0.040%
2/17/2025	Bridgeway Capital Management LLC	109,586	$0.16M	0.0%	+24.4%	0.246%
2/17/2025	Bank of America Corp DE	2,078,875	$3.08M	0.0%	-3.5%	4.665%
2/14/2025	Jane Street Group LLC	54,713	$81K	0.0%	+261.2%	0.123%
2/14/2025	Northern Trust Corp	244,390	$0.36M	0.0%	+7.3%	0.548%
2/14/2025	Dimensional Fund Advisors LP	194,746	$0.29M	0.0%	-24.5%	0.437%
2/13/2025	Regal Investment Advisors LLC	27,204	$40K	0.0%	+88.1%	0.061%
2/13/2025	Walleye Capital LLC	96,850	$0.14M	0.0%	-11.1%	0.217%
2/13/2025	Renaissance Technologies LLC	56,900	$84K	0.0%	-62.6%	0.128%
2/12/2025	Geode Capital Management LLC	702,558	$1.04M	0.0%	+2.4%	1.577%
2/12/2025	JPMorgan Chase & Co.	62,928	$93K	0.0%	+372.4%	0.141%
2/5/2025	Levin Capital Strategies L.P.	50,000	$74K	0.0%	N/A	0.112%
2/4/2025	Bank of New York Mellon Corp	71,300	$0.11M	0.0%	+23.1%	0.160%
11/19/2024	Barclays PLC	54,810	$0.12M	0.0%	+130.1%	0.123%
11/16/2024	Geode Capital Management LLC	685,989	$1.45M	0.0%	+6.3%	1.539%
11/15/2024	Barclays PLC	54,810	$0.12M	0.0%	+130.1%	0.123%
11/15/2024	XTX Topco Ltd	21,209	$45K	0.0%	N/A	0.048%
11/15/2024	Jane Street Group LLC	15,149	$32K	0.0%	-47.0%	0.034%
11/15/2024	State Street Corp	476,439	$1.01M	0.0%	+12.4%	1.069%
11/15/2024	Point72 Asset Management L.P.	109,816	$0.23M	0.0%	-70.5%	0.246%
11/14/2024	PFM Health Sciences LP	3,398,747	$7.21M	0.4%	+4.9%	7.627%
11/14/2024	Walleye Capital LLC	108,968	$0.23M	0.0%	+10.7%	0.245%
10/3/2024	SG Americas Securities LLC	13,517	$29K	0.0%	N/A	0.031%
9/16/2024	Point72 DIFC Ltd	14,046	$34K	0.0%	N/A	0.032%
9/16/2024	Cubist Systematic Strategies LLC	28,371	$69K	0.0%	-30.2%	0.065%
8/16/2024	Murchinson Ltd.	62,500	$0.15M	0.0%	N/A	0.144%
8/15/2024	Millennium Management LLC	1,110,298	$2.71M	0.0%	+96.4%	2.555%
8/14/2024	Cubist Systematic Strategies LLC	28,371	$69K	0.0%	-30.2%	0.065%
8/14/2024	Murchinson Ltd.	62,500	$0.15M	0.0%	N/A	0.144%
8/14/2024	Point72 DIFC Ltd	14,046	$34K	0.0%	N/A	0.032%
8/14/2024	Marshall Wace LLP	134,184	$0.33M	0.0%	+410.5%	0.309%
8/13/2024	Rubric Capital Management LP	1,333,893	$3.26M	0.1%	-17.7%	3.070%
8/9/2024	Renaissance Technologies LLC	171,000	$0.42M	0.0%	+103.1%	0.394%
8/9/2024	Dimensional Fund Advisors LP	160,577	$0.39M	0.0%	+43.9%	0.370%
8/8/2024	American Century Companies Inc.	37,634	$92K	0.0%	+50.7%	0.087%
8/6/2024	Acadian Asset Management LLC	212,296	$0.52M	0.0%	+22.8%	0.489%
8/1/2024	Rhumbline Advisers	32,547	$79K	0.0%	N/A	0.075%
7/26/2024	Bank of New York Mellon Corp	67,644	$0.17M	0.0%	N/A	0.156%
5/16/2024	Janus Henderson Group PLC	1,688,054	$10.92M	0.0%	N/A	3.884%
5/10/2024	Acadian Asset Management LLC	172,883	$1.12M	0.0%	+119.8%	0.399%
5/10/2024	Vanguard Group Inc.	1,107,347	$7.18M	0.0%	+26.8%	2.554%
5/9/2024	HBK Sorce Advisory LLC	13,227	$86K	0.0%	-50.0%	0.031%
4/19/2024	Denali Advisors LLC	26,600	$0.17M	0.1%	N/A	0.061%
2/15/2024	PFM Health Sciences LP	3,468,177	$13.39M	0.8%	+35.6%	8.529%
2/14/2024	Lighthouse Investment Partners LLC	22,472	$87K	0.0%	N/A	0.055%
2/5/2024	Certuity LLC	10,000	$39K	0.0%	N/A	0.028%
2/1/2024	Financial Perspectives Inc	6,750	$26K	0.0%	+80.0%	0.019%
8/4/2023	HBK Sorce Advisory LLC	26,454	$81K	0.0%	-50.0%	0.074%
5/15/2023	Rubric Capital Management LP	1,935,357	$5.03M	0.1%	+5.4%	5.449%
5/8/2023	Bailard Inc.	18,127	$47K	0.0%	N/A	0.051%
2/9/2023	Chicago Partners Investment Group LLC	10,729	$41K	0.0%	N/A	0.035%
11/15/2022	PFM Health Sciences LP	2,815,654	$12.70M	0.5%	+62.7%	9.158%
11/15/2022	Platinum Investment Management Ltd.	109,530	$0.49M	0.0%	-48.7%	0.356%
11/15/2022	Laurion Capital Management LP	522,900	$2.36M	0.0%	-2.3%	1.700%
11/14/2022	Ergoteles LLC	114,595	$0.52M	0.0%	-11.2%	0.388%
11/14/2022	Rubric Capital Management LP	966,879	$4.36M	0.2%	+371.7%	3.274%
10/25/2022	Denali Advisors LLC	5,900	$27K	0.0%	N/A	0.020%
8/15/2022	Laurion Capital Management LP	535,160	$2.19M	0.0%	N/A	1.935%
8/8/2022	Y Intercept Hong Kong Ltd	11,124	$45K	0.0%	N/A	0.040%
7/27/2022	Bailard Inc.	21,200	$87K	0.0%	N/A	0.077%

Data available starting January 2016

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $0.96

$0.91

$0.97

50 Day Range

MA: $0.47

$0.31

$0.99

52 Week Range

Now: $0.96

$0.27

$2.38

Volume

970,513 shs

Average Volume

20,085,872 shs

Market Capitalization

$46.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of Werewolf Therapeutics?: Werewolf Therapeutics' top insider investors include:
Ansbert Gadicke (Major Shareholder)
Bioventures 2014 LP Mpm (Major Shareholder)
Ra Capital Management, LP (Director)
Luke Evnin (Director)
Ra Capital Management, LP (Major Shareholder)
Reid Leonard (COO)
Learn More about top insider investors at Werewolf Therapeutics.
Who are the major institutional investors of Werewolf Therapeutics?: Werewolf Therapeutics' top institutional investors include:
Bank of America Corp DE — 0.64%
BlackRock Inc. — 0.21%
Learn More about top institutional investors of Werewolf Therapeutics stock.
Which major investors are buying Werewolf Therapeutics stock?: Within the last quarter, HOWL stock was purchased by institutional investors including:
Bank of America Corp DE
BlackRock Inc.